Annual FCF
-$186.95 M
-$65.57 M-54.02%
December 31, 2024
Summary
- As of March 8, 2025, ABCL annual free cash flow is -$186.95 million, with the most recent change of -$65.57 million (-54.02%) on December 31, 2024.
- During the last 3 years, ABCL annual FCF has fallen by -$373.08 million (-200.44%).
- ABCL annual FCF is now -191.33% below its all-time high of $204.70 million, reached on December 31, 2022.
Performance
ABCL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$23.63 M
+$23.77 M+50.15%
December 31, 2024
Summary
- As of March 8, 2025, ABCL quarterly free cash flow is -$23.63 million, with the most recent change of +$23.77 million (+50.15%) on December 31, 2024.
- Over the past year, ABCL quarterly FCF has increased by +$23.77 million (+50.15%).
- ABCL quarterly FCF is now -109.78% below its all-time high of $241.69 million, reached on June 30, 2022.
Performance
ABCL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$186.95 M
+$10.97 M+5.54%
December 31, 2024
Summary
- As of March 8, 2025, ABCL TTM free cash flow is -$186.95 million, with the most recent change of +$10.97 million (+5.54%) on December 31, 2024.
- Over the past year, ABCL TTM FCF has increased by +$10.97 million (+5.54%).
- ABCL TTM FCF is now -165.19% below its all-time high of $286.77 million, reached on June 30, 2022.
Performance
ABCL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ABCL Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -54.0% | +50.1% | +5.5% |
3 y3 years | -200.4% | +50.1% | +5.5% |
5 y5 years | -10000.0% | +50.1% | +5.5% |
ABCL Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -191.3% | at low | -109.8% | +83.3% | -165.2% | +5.5% |
5 y | 5-year | -191.3% | at low | -109.8% | +83.3% | -165.2% | +5.5% |
alltime | all time | -191.3% | at low | -109.8% | +83.3% | -165.2% | +5.5% |
AbCellera Biologics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$186.95 M(+54.0%) | -$23.63 M(-50.1%) | -$186.95 M(-5.5%) |
Sep 2024 | - | -$47.40 M(-5.3%) | -$197.92 M(+15.8%) |
Jun 2024 | - | -$50.08 M(-24.0%) | -$170.96 M(+33.4%) |
Mar 2024 | - | -$65.85 M(+90.3%) | -$128.19 M(+5.6%) |
Dec 2023 | -$121.38 M(-159.3%) | -$34.60 M(+69.3%) | -$121.38 M(+78.0%) |
Sep 2023 | - | -$20.44 M(+180.0%) | -$68.20 M(-63.9%) |
Jun 2023 | - | -$7.30 M(-87.6%) | -$189.06 M(-415.5%) |
Mar 2023 | - | -$59.05 M(-417.8%) | $59.93 M(-70.7%) |
Dec 2022 | $204.70 M | $18.58 M(-113.2%) | $204.70 M(+28.0%) |
Sep 2022 | - | -$141.30 M(-158.5%) | $159.98 M(-44.2%) |
Jun 2022 | - | $241.69 M(+181.9%) | $286.77 M(+72.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $85.72 M(-427.9%) | $165.96 M(-10.8%) |
Dec 2021 | $186.13 M(+2221.7%) | -$26.14 M(+80.2%) | $186.13 M(-12.2%) |
Sep 2021 | - | -$14.51 M(-112.0%) | $212.05 M(-3.1%) |
Jun 2021 | - | $120.88 M(+14.1%) | $218.87 M(+82.0%) |
Mar 2021 | - | $105.90 M(<-9900.0%) | $120.27 M(+1400.1%) |
Dec 2020 | $8.02 M(-715.3%) | -$224.00 K(-97.1%) | $8.02 M(-2.7%) |
Sep 2020 | - | -$7.69 M(-134.5%) | $8.24 M(-48.3%) |
Jun 2020 | - | $22.27 M(-450.9%) | $15.93 M(-350.9%) |
Mar 2020 | - | -$6.35 M | -$6.35 M |
Dec 2019 | -$1.30 M(-25.2%) | - | - |
Dec 2018 | -$1.74 M | - | - |
FAQ
- What is AbCellera Biologics annual free cash flow?
- What is the all time high annual FCF for AbCellera Biologics?
- What is AbCellera Biologics annual FCF year-on-year change?
- What is AbCellera Biologics quarterly free cash flow?
- What is the all time high quarterly FCF for AbCellera Biologics?
- What is AbCellera Biologics quarterly FCF year-on-year change?
- What is AbCellera Biologics TTM free cash flow?
- What is the all time high TTM FCF for AbCellera Biologics?
- What is AbCellera Biologics TTM FCF year-on-year change?
What is AbCellera Biologics annual free cash flow?
The current annual FCF of ABCL is -$186.95 M
What is the all time high annual FCF for AbCellera Biologics?
AbCellera Biologics all-time high annual free cash flow is $204.70 M
What is AbCellera Biologics annual FCF year-on-year change?
Over the past year, ABCL annual free cash flow has changed by -$65.57 M (-54.02%)
What is AbCellera Biologics quarterly free cash flow?
The current quarterly FCF of ABCL is -$23.63 M
What is the all time high quarterly FCF for AbCellera Biologics?
AbCellera Biologics all-time high quarterly free cash flow is $241.69 M
What is AbCellera Biologics quarterly FCF year-on-year change?
Over the past year, ABCL quarterly free cash flow has changed by +$23.77 M (+50.15%)
What is AbCellera Biologics TTM free cash flow?
The current TTM FCF of ABCL is -$186.95 M
What is the all time high TTM FCF for AbCellera Biologics?
AbCellera Biologics all-time high TTM free cash flow is $286.77 M
What is AbCellera Biologics TTM FCF year-on-year change?
Over the past year, ABCL TTM free cash flow has changed by +$10.97 M (+5.54%)